Cargando…

Idiopathic Pulmonary Hemosiderosis: The Great Hemolytic Anemia Mimicker

Idiopathic pulmonary hemosiderosis (IPH) is a rare, potentially fatal disease characterized by recurrent diffuse alveolar hemorrhage. Presentation varies, and delay in diagnosis and treatment can result in respiratory complications and increased mortality. It is imperative to consider IPH in the dif...

Descripción completa

Detalles Bibliográficos
Autor principal: Chan, Jaclyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339854/
https://www.ncbi.nlm.nih.gov/pubmed/37456468
http://dx.doi.org/10.7759/cureus.40362
_version_ 1785071938257813504
author Chan, Jaclyn
author_facet Chan, Jaclyn
author_sort Chan, Jaclyn
collection PubMed
description Idiopathic pulmonary hemosiderosis (IPH) is a rare, potentially fatal disease characterized by recurrent diffuse alveolar hemorrhage. Presentation varies, and delay in diagnosis and treatment can result in respiratory complications and increased mortality. It is imperative to consider IPH in the differential of a patient presenting with transfusion-dependent microcytic anemia and concomitant pulmonary symptoms. This case series describes two pediatric patients with persistent severe microcytic anemia despite multiple blood transfusions. Both patients underwent extensive workup for their anemia, and ultimately, their respiratory symptoms led to their diagnosis of IPH. Both were then managed with long-term corticosteroids and had significant clinical improvement.
format Online
Article
Text
id pubmed-10339854
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-103398542023-07-14 Idiopathic Pulmonary Hemosiderosis: The Great Hemolytic Anemia Mimicker Chan, Jaclyn Cureus Pediatrics Idiopathic pulmonary hemosiderosis (IPH) is a rare, potentially fatal disease characterized by recurrent diffuse alveolar hemorrhage. Presentation varies, and delay in diagnosis and treatment can result in respiratory complications and increased mortality. It is imperative to consider IPH in the differential of a patient presenting with transfusion-dependent microcytic anemia and concomitant pulmonary symptoms. This case series describes two pediatric patients with persistent severe microcytic anemia despite multiple blood transfusions. Both patients underwent extensive workup for their anemia, and ultimately, their respiratory symptoms led to their diagnosis of IPH. Both were then managed with long-term corticosteroids and had significant clinical improvement. Cureus 2023-06-13 /pmc/articles/PMC10339854/ /pubmed/37456468 http://dx.doi.org/10.7759/cureus.40362 Text en Copyright © 2023, Chan et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pediatrics
Chan, Jaclyn
Idiopathic Pulmonary Hemosiderosis: The Great Hemolytic Anemia Mimicker
title Idiopathic Pulmonary Hemosiderosis: The Great Hemolytic Anemia Mimicker
title_full Idiopathic Pulmonary Hemosiderosis: The Great Hemolytic Anemia Mimicker
title_fullStr Idiopathic Pulmonary Hemosiderosis: The Great Hemolytic Anemia Mimicker
title_full_unstemmed Idiopathic Pulmonary Hemosiderosis: The Great Hemolytic Anemia Mimicker
title_short Idiopathic Pulmonary Hemosiderosis: The Great Hemolytic Anemia Mimicker
title_sort idiopathic pulmonary hemosiderosis: the great hemolytic anemia mimicker
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339854/
https://www.ncbi.nlm.nih.gov/pubmed/37456468
http://dx.doi.org/10.7759/cureus.40362
work_keys_str_mv AT chanjaclyn idiopathicpulmonaryhemosiderosisthegreathemolyticanemiamimicker